Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>Jyoti Nangalia, Elli Papaemmanuil, Anthony R. Green et al.|New England Journal of Medicine|2013Cited by 1.7k
Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosisPaola Guglielmelli|Blood|2011Cited by 149
Mutations and thrombosis in essential thrombocythemiaPaola Guglielmelli, Ayalew Tefferi, Naseema Gangat et al.|Blood Cancer Journal|2021Cited by 41
Genetic lesions disrupting calreticulin 3′‐untranslated region in <scp>JAK2</scp> mutation‐negative polycythemia <scp>vera</scp>Alberto Quattrocchi, Clara Nervi, Carlo Maiorca et al.|American Journal of Hematology|2020Cited by 9
Artificial-Intelligence, Data-Driven, Comprehensive Classification of Myeloid Neoplasms Based on Genomic, Morphological and Histological FeaturesLuca Lanino, David Quintela, Saverio D’Amico et al.|Blood|2024Cited by 2